More recently, it was found that miR-101 was significantly reduced in sunitinib-treated RCC tissues and the ectopic expression of miR-101 inhibited RCC cell aggressiveness through its targeting of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) [9]. The gene discussed is UHRF1; the disease is renal cell carcinoma.